MMP2 and gastric cancer: Silymarin et al. reduced the expression of MMP-2 and MMP-9 by down-regulating the P38MAPK signaling pathway, thereby inhibiting the invasion and metastasis of human GC SGC7901 cells (Lu et al., 2021).